Middle East Pharmaceutical Industries 将来の成長

Middle East Pharmaceutical Industries is forecast to grow revenue at 13.3% per annum.

n/a

収益成長率

n/a

EPS成長率

更新なし

業績と収益の成長予測

SASE:4016 - アナリストの将来予測と過去の財務データ ( )SAR Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
12/31/2026	510	N/A	N/A	N/A	1
12/31/2025	446	N/A	N/A	N/A	1
12/31/2024	385	N/A	N/A	N/A	1
6/30/2024	367	79	73	104	N/A
3/31/2024	359	76	71	104	N/A
12/31/2023	338	66	62	93	N/A
9/30/2023	328	63	64	92	N/A
6/30/2023	318	59	66	91	N/A
3/31/2023	291	50	62	84	N/A
12/31/2022	303	59	48	69	N/A
12/31/2021	287	66	16	41	N/A
12/31/2020	302	73	5	44	N/A

収入対貯蓄率: Insufficient data to determine if 4016's forecast earnings growth is above the savings rate (14.5%).

収益対市場: Insufficient data to determine if 4016's earnings are forecast to grow faster than the SA market

高成長収益: Insufficient data to determine if 4016's earnings are expected to grow significantly over the next 3 years.

収益対市場: 4016's revenue (13.3% per year) is forecast to grow faster than the SA market (1.3% per year).

高い収益成長: 4016's revenue (13.3% per year) is forecast to grow slower than 20% per year.

将来のROE: Insufficient data to determine if 4016's Return on Equity is forecast to be high in 3 years time